Genetic diversity in the human major histocompatibility complex: Lessons for vaccination approaches to HIV infection

Community Genetics

Volumn 5, Issue 3, 2002, Pages 162-166

  Mehra, N K ^a   Kaur, G ^a   Jaini, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

AH8.1; CCR5; Genetic diversity; HIV; MHC

Indexed keywords

HLA A ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASIAN; AUTOIMMUNITY; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE RESPONSE; IMMUNOGENETICS; INDIAN; INFECTION PREVENTION; MAJOR HISTOCOMPATIBILITY COMPLEX; POPULATION GENETICS; PRIORITY JOURNAL; REGULATORY MECHANISM; SOCIOECONOMICS; VACCINATION;

EID: 0036435456     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066330     Document Type: Article

References (16)

1. Mehra NK, Kaur G: Perspectives in New Biology and Molecular Medicine. Mol Aspects Immunobiol 2000;1:4-7.
2. MacDonald KS, Matukas L, Embree JE, Fowke K, Kimani J, Nagelkerke NJ, Oyugi J, Kiama P, Kaul R, Luscher MA, Rowland-Jones S, Ndinya-Achola J, Ngugi E, Bwayo JJ, Plummer FA: Human leucocyte antigen super-types and immune susceptibility to HIV-1, implications for vaccine design. Immunol Lett 2001;79:151-157.
3. Sette A, Sidney J: Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenet 1999;50:201-212.
4. Shiina T, Tamiya G, Oka A, Takishima N, Onoko H: Genome sequencing analysis of the 1.8 Mb entire human MHC class I region. Immunol Rev 1999;167:193-199.
5. Mehra NK, Kaur G, Jaini R: Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population. Hum Immunol 2001;63:24-29.
6. Mehra NK, Jaini R, Rajalingam R, Balamurugan A, Kaur G: Molecular diversity of HLA-A*02 in Asian Indians: Predominance of A*0211. Tissue Antigens 2001;57:502-507.
7. Jaini R, Naruse T, Kanga U, Eikkawa E, Kaur G, Inoko H, Mehra NK: Molecular diversity of HLA-A*19 group of alleles in North Indians: Possible oriental influence. Tissue Antigens, in press.
8. Kaur G, Sarkar N, Bhatnagar S, Kumar S, Rap-thap CC, Bhan MK, Mehra NK: Pediatric Celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Hum Immunol 2002; 63:677-682.
9. Mehra NK, Kaur G, Kanga U, Tandon N: Immunogenetics of autoimmune diseases in Asian Indians. Ann NY Acad Sci 2002;958: 1-4.
10. Carrington M, Nelson GW, Martin MP, Kiss-ner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ: HLA and HIV-1: Heterozygote advantage and B*35-Cw"04 disadvantage. Science 1999;283:1748-1752.
11. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Gall SL, Raposo G, Schwartz O, Benaroch P: HIV-1 nef impairs MHC class II antigen presentation and surface expression. Proc Nat Acad Sci USA 2001;98:12144-12149.
12. Steel CM, Ludlam CA, Beatson D, Peutherer JF, Cuthbert RJG, Simmonds P, Morrison H, Jones M: HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1988;i:1185-1188.
13. Sheppard HW, Celum C, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buch-binder SP: HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: Acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr 2002;29: 307-313.
14. Hussain S, Goila R, Shahi S, Banerjea A: First report of a healthy Indian heterozygous for Δ32 mutant of HIV-1-co-receptor-CCR5 gene. Gene 1998;207:141-147.
15. Goila R, Kumar F, Banerjea AC: MIP1α promoter polymorphism in humans and monkeys: Identification of two polymorphic regions characterized by the insertion of unique sequences in monkeys. AIDS 2000;15:1065-1067.
16. Ramamoorti N, Kumarvelu J, Shanmugasun-daram GK, Rani K, Banerjae AC: High frequency of G to A transition mutation in the stromal cell derived factor-1 gene in India, a chemokine that blocks HIV-1 (X4) infection: Multiple proteins bind to 3′ untranslated region of SDF-1 RNA. Genes Immun 2001:2: 408-410.